Join Now
Tuesday, November 17, 2026
HomeGrowthCase StudiesElizabeth Holmes's Partner Raised Up to $20 Million for a Blood-Testing Startup....

Elizabeth Holmes’s Partner Raised Up to $20 Million for a Blood-Testing Startup. On Camera, He Says: “Put the Band Back Together.”

Elizabeth Holmes went to prison for lying about a blood-testing machine. Her partner just raised as much as $20 million for a blood-testing startup, and he isn’t exactly running from the comparison.

“The idea is to put the band back together and do it all again,” Billy Evans says in a new A24 documentary about the couple.

His startup, Haemanthus, says a laser-based device can detect disease in blood, saliva and urine. It has no commercial product and no independently validated results, Fortune reported Sunday. Read that again: no product, no proof, up to $20 million.

So who is writing those checks? According to Fortune, the first $3.5 million came from friends and family. Then Evans pitched wealthy investors in Austin and the San Francisco Bay Area for about $15 million more. It helps to be an MIT graduate whose grandparents founded Evans Hotels, a group of upscale San Diego hotels, A&E reported. Early money doesn’t pay for proof. It pays for access.

Executives at a C-SUITE NETWORK receptionBe our guestYour next big opportunity could be in a room you're not in.Meet CEOs, founders and owners at a reception in your city or online. Your first event is on us.Request my guest seat →

The Part Investors Should Read Twice

The CTO is gone, and the stories don’t match. Former CTO Joseph LaChapelle, one of two inventors named on the company’s patent, says he resigned in March over a conflict with another startup he founded. Evans has described it differently, saying he let him go, according to a person who spoke with him, Fortune reported. When the name on your patent walks out, people notice.

The pitch name-dropped Palantir. Evans claimed early Palantir employees had invested, according to a person who spoke with him, Fortune reported.

The first customers will be pets. Haemanthus plans to start with veterinary testing, a less regulated market than human diagnostics. A smart place to start if you’d like fewer regulators asking questions.

Holmes’s role is disputed. NPR reported in 2025 that Holmes had been advising Evans from prison. The company denied she was involved and posted on X: “This is not Theranos 2.0,” NPR reported. It’s the one sentence a company says whether it’s true or not, which is exactly the problem.

Even Evans has doubts. “I might think this is like the dumbest thing I’ve ever done,” he said at the All-In Summit, Fortune reported.

The documentary, You Can See Everything, from Nathan Fielder and Lance Oppenheim, opened Oct. 16 with a 100% score on Rotten Tomatoes. Fielder’s verdict on Holmes, to Variety: “I know she’s a liar,” according to Wikipedia.

Before Your Next Meeting

Here’s what this means for your business:

  • If a skeptic asked for proof tomorrow, what would you show them? Haemanthus has money and a patent, but Fortune found no independently validated results. Write down the one piece of evidence that proves your product works. If you can’t, get it before your next pitch.
  • If a key person left tomorrow, what story would they tell? The CTO named on the patent is gone, and the two sides tell it differently. Who on your team would you least want telling their version, and what are you doing to keep that version good?
  • What’s the first thing people think of when they hear your name? Haemanthus had to publicly post “This is not Theranos 2.0.” If your history walks into the room before you do, address it head-on in the first five minutes.

Sources: Fortune; A&E; NPR via WFAE; Wikipedia: You Can See Everything.

Want the stories your boardroom hasn’t heard yet? Get them first inside C-SUITE NETWORK™.

C-SUITE NETWORK™ Editors
C-SUITE NETWORK™ Editors
Original reporting and stories from the editorial team at C-SUITE NETWORK™: the founder stories, brand histories, and business ideas worth an executive’s time.
RELATED ARTICLES

Most Popular

C-Suite TV · From the NYSETrust Is the New Currency: How Dow Jones Wins in the Age of AI with Josh Stinchcomb22 min · Watch now
Members talking at a C-Suite Network reception
Before C-Suite, I was building in isolation. Now I'm surrounded by executives who push me forward.
Dan E. Silberberg · Founder & CEO, Entelechy Join for $100/moBook a 15-minute call Up to 600 events a year with founders and CEOs running real companies.
WatchC-Suite TV · Filmed at the NYSE
Watch now
Trust Is the New Currency: How Dow Jones Wins in the Age of AI with Josh Stinchcomb22 min · Watch now AI Is Coming for More Than Jobs: The Fight to Rehumanize the Future with Denis JacquetAI Is Leveling the Playing Field: How Small Businesses Can Compete and Win with Robin AlexThe Future of Financial Advice is More Human, Not Less with CJ Davidson All episodes on C-Suite TV →
Have something worth saying?
Get seen. Get heard.

Get listed as an expert, publish your articles, launch or bring over your podcast, or put your show on C-Suite TV: Roku, Apple TV, Fire TV and every major podcast app, in front of senior business leaders.

Get seen & heardSee how it works
Come as a guest
See the room before you join.

Up to 600 events a year, and every one is open to guests except council meetings. Most people start at a city reception, and your first one is on us. Members get free entry to all of them.

Request my guest seatMembership: $100/mo
→Member account & business toolsThe tools included with membership: a CRM for your contacts, email marketing, calendar booking and landing pages ✎Contributor PortalPublishing and show resources for contributors, plus shared files Not a member yet? See membership →
Get visibility
Make the market know your name.

Publish your articles on C-Suite Network, get your advisor listing and host your own show on C-Suite Radio and TV.

Get seen & heard$250/mo total, including membership